Recurrent Lung Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Recurrent Lung Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer (NCT02417701) | National Cancer Institute (NCI) | 2016-10-06 |
Track Recurrent Lung Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.